Item
Sodium Ascorbate (Sodium Ascorbate)
Sodium Ascorbate
Nutrient / Vitamin
Attributes
- Gluten-free
- Halal
- Ingredient declaration
- Kosher
- PHO-free
- Ready-to-Eat (RTE)
- Vegan
- Non-GMO
Locations
| Location name | Address |
|---|---|
| Atlantic Chemicals Trading of North America, Inc | 2 Oliver St Suite 602 Boston, MA 02109 |
| CSPC Weisheng Pharmaceutical | No. 236 Huanghe Road New-High Technology Industry Development Shijiazhung, Shijiazhung N/A CHN |
| Shandong Luwei Pharmaceutical | Shuangfeng Industrial Park Zichuan District Zibo City, Shandong Province N/A CHN |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| CoA Sample | Tianli Pharmaceutical Co | 21801924.pdf | 10/17/2019 | 10/16/2021 |
| CoA Sample | Tianli Pharmaceutical Co | 21801924.pdf | 10/17/2019 | 10/16/2021 |
| CoA Sample | Shandong Luwei Pharmaceutical | 240222002_COA.pdf | 5/18/2024 | 5/18/2026 |
| Allergens | Tianli Pharmaceutical Co | Allergens.pdf | 4/21/2020 | 4/21/2022 |
| Allergens | CSPC Weisheng Pharmaceutical | Allergens.pdf | 6/22/2023 | 6/21/2025 |
| Allergens | Shandong Luwei Pharmaceutical | Allergens.pdf | 9/20/2024 | 9/20/2026 |
| Allergens | ACT of NA, Inc, - CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd., China | Allergens.pdf | 10/9/2024 | 10/9/2026 |
| Gluten | CSPC Weisheng Pharmaceutical | Allergens-VCNa-CSPC Weisheng.pdf | 4/2/2025 | 4/2/2027 |
| Gluten | Shandong Luwei Pharmaceutical | Allergens-VCNa-Luwei.pdf | 8/17/2023 | 8/16/2025 |
| Vegan/Vegetarian Statement | Shandong Luwei Pharmaceutical | Allergens-VCNa-Luwei.pdf | 8/17/2023 | 8/16/2025 |
| Lot Code | Tianli Pharmaceutical Co | Batch Code explanation-Tianli.pdf | 1/1/2020 | 12/31/2022 |
| BSE - TSE | CSPC Weisheng Pharmaceutical | BSE_TSE-VCNa-Weisheng (2).pdf | 1/2/2020 | 1/1/2023 |
| Lot Code | Shandong Luwei Pharmaceutical | Change Control-VCNa-Luwei.pdf | 2/1/2023 | 1/31/2026 |
| Ingredient Statement | Shandong Luwei Pharmaceutical | Composition-VCNa-Luwei.pdf | 8/13/2024 | 8/13/2027 |
| Country of Origin | Tianli Pharmaceutical Co | Country of Origin.pdf | 4/21/2020 | 4/21/2023 |
| Country of Origin | CSPC Weisheng Pharmaceutical | Country of Origin.pdf | 3/1/2024 | 3/1/2027 |
| Country of Origin | Shandong Luwei Pharmaceutical | Country of Origin.pdf | 9/20/2024 | 9/20/2027 |
| Country of Origin | ACT of NA, Inc, - CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd., China | Country of Origin.pdf | 10/9/2024 | 10/9/2027 |
| WADA/NSF/NFL Statement | CSPC Weisheng Pharmaceutical | Doping Free (WADA)-VCNa-Weisheng.pdf | 5/11/2023 | 5/10/2025 |
| HACCP Process Flow Diagram | Tianli Pharmaceutical Co | Flow Chart with CCPs-VCNa-Tianli.pdf | 2/1/2020 | 1/31/2022 |
| HACCP Process Flow Diagram | Shandong Luwei Pharmaceutical | Flow Chart witrh CCPs-VCNa-Luwei (1).pdf | 8/18/2023 | 8/17/2025 |
| FSVP Assessment Form | Shandong Luwei Pharmaceutical | FSVP Assessment Form.pdf | 10/17/2023 | 10/16/2024 |
| FSVP Assessment Form | CSPC Weisheng Pharmaceutical | FSVP Assessment Form.pdf | 12/17/2024 | 12/17/2025 |
| GMO | Shandong Luwei Pharmaceutical | GMO-VCNa-Luwei.pdf | 8/17/2023 | 8/16/2025 |
| GMO | Tianli Pharmaceutical Co | GMO-VCNa-Tianli.pdf | 3/9/2020 | 3/9/2022 |
| GMO | CSPC Weisheng Pharmaceutical | GMO-VCNa-Weisheng.pdf | 11/1/2013 | 11/1/2015 |
| HACCP Process Flow Diagram | CSPC Weisheng Pharmaceutical | HACCP Flow Chart (CCP)-VCNa-CSPC Weisheng.pdf | 11/26/2024 | 11/26/2026 |
| HACCP | Tianli Pharmaceutical Co | HACCP Plan-VCNa-Tianli.pdf | 3/11/2020 | 3/11/2023 |
| HACCP | ACT of NA, Inc, - CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd., China | HACCP plan-VCNa-Weisheng.pdf | 10/9/2024 | 10/9/2027 |
| HACCP | Shandong Luwei Pharmaceutical | HACCP-VCNa-Luwei.pdf | 10/2/2024 | 10/2/2027 |
| Halal | Shandong Luwei Pharmaceutical | Halal (MUI)-Luwei-29.11.2026.pdf | 11/30/2022 | 11/29/2026 |
| Halal | Tianli Pharmaceutical Co | Halal Ifanca-Tianli-31.03.2021 (1).pdf | 4/15/2020 | 3/31/2021 |
| Halal | ACT of NA, Inc, - CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd., China | HALAL-CSPC Weisheng-27.07.2026.pdf | 7/28/2022 | 7/27/2026 |
| Heavy Metal | Shandong Luwei Pharmaceutical | Heavy Metals-VCNa-Luwei.pdf | 8/17/2023 | 8/16/2025 |
| Heavy Metal | Tianli Pharmaceutical Co | Heavy Metals-VCNa-Tianli.pdf | 3/11/2020 | 3/11/2022 |
| Heavy Metal | CSPC Weisheng Pharmaceutical | Heavy Metals-VCNa-Weisheng (1).pdf | 1/3/2020 | 1/2/2022 |
| Irradiation Status Statement | CSPC Weisheng Pharmaceutical | Ionizing_Radiation-VCNa-Weisheng.pdf | 11/1/2013 | 11/1/2015 |
| Item Questionnaire | CSPC Weisheng Pharmaceutical | Item Questionnaire.pdf | 7/16/2023 | 7/15/2026 |
| Item Questionnaire | Shandong Luwei Pharmaceutical | Item Questionnaire.pdf | 10/7/2024 | 10/7/2027 |
| Kosher | CSPC Weisheng Pharmaceutical | Kosher-CSPC Weisheng-31.08.2025.pdf | 4/27/2024 | 8/31/2025 |
| Kosher | ACT of NA, Inc, - CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd., China | Kosher-CSPC Weisheng-31.08.2025.pdf | 8/27/2024 | 8/31/2025 |
| Kosher | Shandong Luwei Pharmaceutical | Kosher-Luwei-31.03.2026.pdf | 3/25/2025 | 3/31/2026 |
| Kosher | Tianli Pharmaceutical Co | Kosher-Shandong Tianli-31052021.pdf | 5/20/2020 | 5/31/2021 |
| Label Sample | Shandong Luwei Pharmaceutical | Label Sample-VCNa-Luwei.pdf | 5/8/2025 | 5/8/2026 |
| Melamine | Tianli Pharmaceutical Co | Melamine Declaration-VCNa-Tianli.pdf | 3/11/2020 | 3/11/2021 |
| Safety Data Sheet (SDS) | Shandong Luwei Pharmaceutical | MSDS-VCNa-Luwei.pdf | 10/10/2024 | 10/10/2027 |
| Safety Data Sheet (SDS) | Tianli Pharmaceutical Co | MSDS-VCNa-Tianli.pdf | 3/2/2020 | 3/2/2022 |
| Safety Data Sheet (SDS) | Tianli Pharmaceutical Co | MSDS-VCNa-Tianli.pdf | 3/2/2020 | 3/2/2022 |
| Safety Data Sheet (SDS) | CSPC Weisheng Pharmaceutical | MSDS-VCNa-Weisheng.pdf | 8/24/2023 | 8/23/2025 |
| National Bioengineered Food Disclosure Standard (Simplified) | Shandong Luwei Pharmaceutical | National Bioengineered Food Disclosure Standard (Simplified).pdf | 1/17/2024 | 1/16/2027 |
| Allergens | Atlantic Chemicals Trading of North America, Inc | NotApplicable_Allergens.pdf | 2/15/2024 | 2/14/2026 |
| Country of Origin | Atlantic Chemicals Trading of North America, Inc | NotApplicable_CountryofOrigin.pdf | 11/1/2024 | 11/1/2027 |
| HACCP | Atlantic Chemicals Trading of North America, Inc | NotApplicable_HACCP.pdf | 11/1/2024 | 11/1/2027 |
| Halal | Atlantic Chemicals Trading of North America, Inc | NotApplicable_Halal.pdf | 11/1/2024 | 11/1/2026 |
| Kosher | Atlantic Chemicals Trading of North America, Inc | NotApplicable_Kosher.pdf | 11/1/2024 | 11/1/2026 |
| Nutrition | Atlantic Chemicals Trading of North America, Inc | NotApplicable_Nutrition.pdf | 11/1/2024 | 11/1/2027 |
| Product Specification Sheet | Atlantic Chemicals Trading of North America, Inc | NotApplicable_ProductSpecificationSheet.pdf | 11/1/2024 | 11/1/2027 |
| Safety Data Sheet (SDS) | Atlantic Chemicals Trading of North America, Inc | NotApplicable_SafetyDataSheetSDS.pdf | 11/1/2024 | 11/1/2027 |
| Suitability Requirements | Atlantic Chemicals Trading of North America, Inc | NotApplicable_SuitabilityRequirements.pdf | 11/1/2024 | 11/1/2027 |
| Nutrition | Tianli Pharmaceutical Co | Nutrition.pdf | 7/2/2020 | 7/2/2023 |
| Nutrition | CSPC Weisheng Pharmaceutical | Nutrition.pdf | 11/21/2022 | 11/20/2025 |
| Nutrition | Shandong Luwei Pharmaceutical | Nutrition.pdf | 9/20/2024 | 9/20/2027 |
| Nutrition | ACT of NA, Inc, - CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd., China | Nutrition.pdf | 10/9/2024 | 10/9/2027 |
| California Prop. 65 | Shandong Luwei Pharmaceutical | Proposition 65-VCNa-Luwei.pdf | 10/18/2023 | 10/17/2025 |
| California Prop. 65 | CSPC Weisheng Pharmaceutical | Proposition 65-VCNa-Weisheng.pdf | 3/27/2024 | 3/27/2026 |
| Pesticide | Shandong Luwei Pharmaceutical | Purity-VCNa-Luwei Pharmaceutical.pdf | 8/14/2024 | 8/14/2026 |
| Food Contact Packaging Certificate of Compliance | Shandong Luwei Pharmaceutical | Requirements for packed Raw Materials-VCNa-Luwei (1).pdf | 8/17/2023 | 8/31/2025 |
| Label Sample | ACT of NA, Inc, - CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd., China | Requirements for packed Raw Materials-VCNa-Weisheng.pdf | 10/9/2024 | 10/9/2025 |
| Residual Statement | CSPC Weisheng Pharmaceutical | Residual Solvents-VCNa-Weisheng.pdf | 1/3/2020 | 1/2/2021 |
| Safety Data Sheet (SDS) | ACT of NA, Inc, - CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd., China | SDS-VCNa-CSPC Weisheng.pdf | 10/9/2024 | 10/9/2027 |
| Safety Data Sheet (SDS) | ACT of NA, Inc, - CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd., China | SDS-VCNa-CSPC Weisheng.pdf | 10/9/2024 | 10/9/2027 |
| Shelf Life | Shandong Luwei Pharmaceutical | Shelf Life-VCNa-Luwei.pdf | 8/17/2023 | 8/16/2026 |
| Product Specification Sheet | Shandong Luwei Pharmaceutical | Specification-BP2016-USP39-FCC10-E301-EP10-VCNa-Luwei.pdf | 10/2/2024 | 10/2/2027 |
| Product Specification Sheet | Tianli Pharmaceutical Co | Specification-VCNa-USP42-FCC11-BP2019-EP9-E301-Tianli (1).pdf | 3/2/2020 | 3/2/2023 |
| Product Specification Sheet | Tianli Pharmaceutical Co | Specification-VCNa-USP42-FCC11-BP2019-EP9-E301-Tianli (1).pdf | 3/2/2020 | 3/2/2023 |
| Product Specification Sheet | CSPC Weisheng Pharmaceutical | Specification-VCNa-USP-FCC-E301-Weishengd.pdf | 1/3/2023 | 1/2/2026 |
| Product Specification Sheet | ACT of NA, Inc, - CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd., China | Specification-VCNa-USP-FCC-E301-Weishengd.pdf | 1/3/2023 | 1/2/2026 |
| Product Specification Sheet | ACT of NA, Inc, - CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd., China | Specification-VCNa-USP-FCC-E301-Weishengd.pdf | 1/3/2023 | 1/2/2026 |
| Suitability Requirements | Tianli Pharmaceutical Co | Suitability Requirements.pdf | 7/2/2020 | 7/2/2023 |
| Suitability Requirements | Shandong Luwei Pharmaceutical | Suitability Requirements.pdf | 10/7/2024 | 10/7/2027 |
| Suitability Requirements | ACT of NA, Inc, - CSPC Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd., China | Suitability Requirements.pdf | 10/9/2024 | 10/9/2027 |
-
Documents Up to Date
- 56 locations
- 54 items
- 606 documents